01
ABOUT THE EVENT
2nd International Virtual Conference on
Staphylococci and Staphylococcal Infections
Staphylococci MEET-2026
February 23–24, 2026
Format: Virtual
Organized by: Impact Research Communications
The Staphylococci MEET-2026 symposium brought together
global experts to discuss the latest advances in
staphylococcal biology, infection dynamics, host-pathogen
interactions, and therapeutic innovation. Across two days,
the program highlighted cutting-edge research on adhesion,
intracellular persistence, biofilm biology, antibiotic
resistance, and novel therapeutic strategies—reflecting
the urgency of tackling staphylococcal infections worldwide.
03
DAY 2
Day 2: Biofilms, Resistance & Therapeutic Innovation
Session IV: Biofilm Biology & Host Interactions
-
Rikke Louise Meyer (Denmark)
revealed emergent roles of extracellular nucleic
acids in biofilms.
-
Balazs Rada (USA)
described impaired neutrophil clearance of
S. aureus in cystic fibrosis.
-
Jeffrey L. Bose (USA)
examined fatty acids beyond membrane building blocks.
-
Xiaogang Wang (USA)
identified extracellular vesicles as novel
biofilm components.
-
Lee Korshoj (USA)
applied single-cell transcriptomics to infection
heterogeneity and immune evasion.
Session V: Antibiotic Resistance & Immune Modulation
-
James P. O'Gara (Ireland)
introduced adjuvants to re-sensitize MRSA
to antibiotics.
-
Maisem Laabei (UK)
showed serum exposure promotes innate immune evasion.
-
Guido Grandi (Italy)
presented pre-clinical immunogenicity studies
on an OMV-based S. aureus vaccine.
-
Kuan-Yi Lu (USA)
demonstrated host-directed adjuvants sensitizing
intracellular persisters.
-
Fan Zhang (USA)
emphasized the essential role of cellular immunity
against S. aureus.
-
Matthieu Degreze (France)
discussed phage selection strategies while
managing resistance risks.
Session VI: Enzymatic Mechanisms & Novel Targets
-
Benedykt Wladyka (Poland)
explored peptidoglycan hydrolases as
anti-staphylococcal agents.
-
Donald R. Ronning (USA)
leveraged knowledge of D-cycloserine tolerance
for drug discovery.
-
Ronan K. Carroll (USA)
investigated adenosine deaminase TadA in S. aureus.
The conference concluded with closing remarks emphasizing
global collaboration and translational innovation in
combating staphylococcal infections.
05
INTERNATIONAL COLLABORATION
Global Participation
Speakers represented USA, France, Germany, UK,
Australia, Denmark, Ireland, Italy, Poland,
and more—underscoring the international scope of
staphylococcal research.